Promoter methylation of certain tumor regulatory genes and hepatocellular carcinoma

The Methylation Status of DNA in Hepatocellular Carcinoma

Assessing TGF β1 Gene Expression as a Prognostic Marker for Hepatocellular Carcinoma Development in HCV patients receiving Direct-Acting Antiviral (DAAs) Therapy

Effect of 5-Azacytidine as A Demethylation Agent on PCNA and RB1 Genes in Hepatocellular Carcinoma Cell Model “HepG2”

Association of CYP24A1 promoter methylation with hepatocellular carcinoma on top of HCV infection

EVALUATION OF HYPERMETHYLATION OF RAS ASSOCIATION DOMAIN FAMILY-1 A AND GLUTATHIONE S-TRANSFERASE PROTEIN-1 GENES AS DIAGNOSTIC MARKER FOR HEPATOCELLULAR CARCINOMA

Decitabine attenuates the anti-cancer effect of doxorubicin by repressing ECDH1 and inducing SNAI1 and BCL2 in HepG2 hepatocellular carcinoma cells.

Value of Hypermethylation (RASSF1A) Promoter Gene among Patients with Hepatocellular Carcinoma

Biochemical study of survivin -31G/C promoter polymorphism in breast Cancer

Correlating DNMT1, PCNA, and RB1 genes as new prognostic biomarkers